NASDAQ
Intercept Pharmaceuticals, Inc. (ICPT) has a current ratio of 2.35x as of Monday, May 25, 2026. This represents a 34.57% decrease compared to its 12-month average of 3.59x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.